Differences in the Volatilomic Urinary Biosignature of Prostate Cancer Patients as a Feasibility Study for the Detection of Potential Biomarkers

Prostate cancer (PCa) continues to be the second most common malignant tumour and the main cause of oncological death in men. Investigating endogenous volatile organic metabolites (VOMs) produced by various metabolic pathways is emerging as a novel, effective, and non-invasive source of information...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccio, Giulia, Berenguer, Cristina V., Perestrelo, Rosa, Pereira, Ferdinando, Berenguer, Pedro, Ornelas, Cristina P., Sousa, Ana Célia, Vital, João Aragão, Pinto, Maria do Carmo, Pereira, Jorge A. M., Greco, Viviana, Câmara, José S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217291/
https://www.ncbi.nlm.nih.gov/pubmed/37232828
http://dx.doi.org/10.3390/curroncol30050370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217291/
https://www.ncbi.nlm.nih.gov/pubmed/37232828
http://dx.doi.org/10.3390/curroncol30050370

Ejemplares similares